SNOA
Sonoma Pharmaceuticals, Inc.
Key Financials
Gross Profit
$7.4M
↑ 35.7%
Net Income
$-3175000
↑ 8.2%
Operating Income
$-2461000
↑ 33.7%
Revenue
$19.5M
↑ 36.7%
Total Liabilities
$10.9M
↑ 17.1%
EPS (Diluted)
$-1.89
↑ 32.3%
Shareholders' Equity
$3.1M
↓ 29.8%
Total Assets
$14.0M
↑ 1.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFA14A | 6/24/2026 | View on SEC |
| 8-K | 6/18/2026 | View on SEC |
| 424B5 | 6/18/2026 | View on SEC |
| 10-K | 6/16/2026 | View on SEC |
| DEF 14A | 5/5/2026 | View on SEC |
| 8-K | 4/30/2026 | View on SEC |
| 424B4 | 4/27/2026 | View on SEC |
| PRE 14A | 4/27/2026 | View on SEC |
| EFFECT | 4/23/2026 | View on SEC |
| S-1/A | 4/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SNOA |
| Company Name | Sonoma Pharmaceuticals, Inc. |
| CIK | 1367083 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | DE |
| Phone | 800-759-9305 |